STAT2 and lung carcinoma: To investigate the role of STAT2 in resistance to cisplatin, we employed three lung cancer cell lines with different expression levels of STAT2: low in A549 cells and high in H196 and Calu-1 cells (SI Appendix, Fig. S7A).